SYNTHESIS OF NOVEL IMIPRIDONE DERIVATIVES AND THEIR EVALUATION FOR THEIR ANTICANCER ACTIVITY

The present invention relates to compounds of formula (I) (I) or pharmaceutically acceptable salts, and stereoisomers thereof, including enantiomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, which are applicable for use in treating cancer diseases. The present invention fu...

Full description

Saved in:
Bibliographic Details
Main Authors CSAMPAI, ANTAL, TAKACS, ANGELA, LAJKO, ESZTER, BOSZE, SZILVIA, MEZO, GABOR, OLAHNE SZABO, RITA, KOVACS, IMRE, CZUCZI, TAMAS, KOHIDAI, LASZLO, MEZO, DIANA, LANG, ORSOLYA, ADAMIS, BALINT, NEMETH, ZSOFIA, BARANY, PETER, MURANYI, JOZSEF
Format Patent
LanguageEnglish
French
Published 10.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to compounds of formula (I) (I) or pharmaceutically acceptable salts, and stereoisomers thereof, including enantiomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, which are applicable for use in treating cancer diseases. The present invention further relates to a pharmaceutical composition comprising the above compounds. La présente invention concerne des composés de formule (I) (I) ou des sels pharmaceutiquement acceptables, et leurs stéréo-isomères, comprenant des énantiomères, des mélanges racémiques, des mélanges d'énantiomères, ou certaines de leurs combinaisons, qui peuvent être appliqués à des fins d'utilisation dans le traitement de maladies cancéreuses. La présente invention concerne également une composition pharmaceutique comprenant les composés susmentionnés.
Bibliography:Application Number: CA20213190787